Advanced Oncotherapy 股息 2024

Advanced Oncotherapy在做什么？

上的 Advanced Oncotherapy PLC is a therapeutic company in London, specializing in the development of advanced and precise radiation therapy solutions. The company was founded in 2005 and has since developed a revolutionary technology that allows for the treatment of cancer cells with the highest precision and minimal to no damage to surrounding tissues. Advanced Oncotherapy's business model aims to provide innovative technology solutions that benefit patients throughout their cancer treatment. The company's various branches include research and development, production, sales and distribution, and clinical trials. Advanced Oncotherapy focuses on a direct customer-client relationship by offering customers interesting treatment options that are tailored to the patient's needs. The flagship product of Advanced Oncotherapy is the LIGHT radiation therapy system, which is globally unique due to its precision, accuracy, and effectiveness in the treatment of cancer. With this system, oncologists and radiologists are able to perform innovative radiation therapy that promises better treatment outcomes. The LIGHT technology is based on the principles of intensity-modulated radiation therapy (IMRT) and next-generation particle therapy (NGPT). By using proton beams, radiation therapy can be focused directly on a specific region of the body where cancerous tissue is spreading. Advanced Oncotherapy offers a wide range of services in the field of radiation therapy, including proton accelerators (PROTON), PET/CT systems (positron emission tomography/computed tomography), CT scanners (computed tomography), and other tools and devices. This product line has been specifically developed for the precise radiation of tumors and for the diagnosis of cancer and other related diseases. Advanced Oncotherapy's customers are primarily hospitals, medical centers, and health authorities. In recent years, Advanced Oncotherapy has collaborated closely with various partners such as CERN (European Organization for Nuclear Research), the Royal Marsden Hospital, University College London, and other institutions to continuously improve and develop its technology and products. Milestones in the company's history include the granting of CE marking for the LIGHT system and support for clinical trials through research-intensive university hospitals. The future of Advanced Oncotherapy looks promising, with a strong growth forecast for the global radiation therapy market. With an increasing demand for innovative solutions for cancer treatment, the company can look forward to a growing customer base and an increasing number of partnerships and collaborations. Advanced Oncotherapy will continue to focus on continuously optimizing its technology to provide cancer patients with the best treatment options. Advanced Oncotherapy 是 Eulerpool.com 上最受欢迎的公司之一。